Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

CAI

Caris Life Sciences Inc

May 29 • 04:00PM ET

16.72

+0.05 0.30 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: CRL ICLR MEDP QGEN DGX LH IQV A DHR TMO

| Held by: VTI VB VBK IBB IWR IWP IDNA IWF IWD VONG

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.47	Insider Own	56.67%	Shs Outstand	282.65M	Perf Week	4.89%
Market Cap	4.73B	Forward P/E	45.26	EPS next Y	0.37	Insider Trans	-0.02%	Shs Float	122.48M	Perf Month	-5.91%
Enterprise Value	4.33B	PEG	-	EPS next Q	0.01	Inst Own	48.09%	Short Float	9.60%	Perf Quarter	-16.98%
Income	-411.43M	P/S	5.21	EPS this Y	134.99%	Inst Trans	17.09%	Short Ratio	4.56	Perf Half Y	-34.64%
Sales	907.29M	P/B	7.96	EPS next Y	159.23%	ROA	4.67%	Short Interest	11.75M	Perf YTD	-38.03%
Book/sh	2.10	P/C	5.74	EPS next 5Y	-	ROE	28.35%	52W High	42.50 -60.66%	Perf Year	-
Cash/sh	2.91	P/FCF	40.83	EPS past 3/5Y	-7.57% -	ROIC	3.34%	52W Low	14.19 17.83%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	33.60	Sales past 3/5Y	62.87% -	Gross Margin	68.72%	Volatility	5.24% 6.43%	Perf 5Y	-
Dividend TTM	-	EV/Sales	4.78	EPS Y/Y TTM	-10.99%	Oper. Margin	11.94%	ATR (14)	1.09	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	6.52	Sales Y/Y TTM	100.51%	Profit Margin	-45.35%	RSI (14)	48.74	Recom	1.38
Dividend Gr. 3/5Y	- -	Current Ratio	7.05	EPS Q/Q	99.60%	SMA20	1.35%	Beta	-	Target Price	28.00
Payout	-	Debt/Eq	0.73	Sales Q/Q	78.78%	SMA50	-7.80%	Rel Volume	0.78	Prev Close	16.67
Employees	1846	LT Debt/Eq	0.72	Earnings	May 07 AMC	SMA200	-33.90%	Avg Volume	2.58M	Price	16.72
IPO	Jun 18, 2025	Option/Short	Yes / Yes	EPS/Sales Surpr.	100.00% 3.23%	Trades		Volume	2,009,679	Change	0.30%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)